Fernando Abdalla

Fernando Abdalla

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2024 in Applied Health Economics and Health Policy
Verified
Journal Article
Closed access
PDF file
NZNéboa Zozaya
Néboa Zozaya
JVJavier Villaseca
Javier Villaseca
IFIrene Fernández
Irene Fernández
FAFernando Abdalla
Fernando Abdalla
BCBenito Cadenas-Noreña
Benito Cadenas-Noreña
ÁHÁlvaro Hidalgo-Vega
Álvaro Hidalgo-Vega

1 November 2019 in Biochemical Pharmacology
Verified
Journal Article
Closed access
MSMarcelo Florencio Passos Silva
Marcelo Florencio Passos Silva
PAPatricia Lucio Alves
Patricia Lucio Alves
RARafaela Fadoni Alponti
Rafaela Fadoni Alponti
PSPaulo Flavio Silveira
Paulo Flavio Silveira
FAFernando Abdalla
Fernando Abdalla

1 January 2014 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
RPRenato Tavares dos Santos Pereira
Renato Tavares dos Santos Pereira
CPCatarina Segreti Porto
Catarina Segreti Porto
FAFernando Abdalla
Fernando Abdalla

24 June 2023 in Behavioural Pharmacology
Verified
Journal Article
Closed access
MSMarcelo Florencio Passos Silva
Marcelo Florencio Passos Silva
CRChristian Pereira Rafael
Christian Pereira Rafael
JSJeferson Rubens Mamona Silva
Jeferson Rubens Mamona Silva
TSTiago Guardia de Souza e Silva
Tiago Guardia de Souza e Silva
RARafaela Fadoni Alponti
Rafaela Fadoni Alponti
FAFernando Abdalla
Fernando Abdalla
Here, we investigate the effects of obesity induced by monosodium glutamate (MSG) on cognitive impairment and whether this model induces any alteration in the affinity, density, and subtypes of muscarinic acetylcholine receptors (mAChRs) in rat hippocampus. Healthy rats were used as controls, and MSG-obese rats were selected via the Lee index > 0.300. The effects of MSG-induced obesity on hippocampal spatial learning and memory processes were evaluated by using the working memory versions of the Morris’ water maze task and the evaluation of mAChRs by binding assay and their subtypes by immunoprecipitation assays. [3H]Quinuclidinyl benzilate specific binding analysis showed that the equilibrium dissociation constant (KD) did not differ between control and MSG, indicating that affinity is not affected by obesity induced by MSG. The maximum number of binding sites (Bmax) obtained in MSG subjects was lower than that obtained from control rats, indicating a decrease in the expression of total mAChRs. Immunoprecipitation assays reveal a decrease in the expression of M1 subtype of MSG when compared with control rats (M2 to M5 subtypes did not differ between control and MSG). We also observed that MSG promotes a disruption of the spatial working memory which was accompanied by a decrease in the M1 mAChR subtype in rat hippocampus, thus suggesting deleterious long-term effects besides the obesity. In conclusion, these findings provide new insights into how obesity can influence spatial learning and memory that is hippocampal-dependent. The data suggest that the M1 mAChR subtype protein expression is a potential therapeutic target.

8 January 2022 in Clinical and Translational Oncology
Verified
Journal Article
Open access
PDF file
NZNéboa Zozaya
Néboa Zozaya
JVJ. Villaseca
J. Villaseca
FAFernando Abdalla
Fernando Abdalla
MCM. A. Calleja
M. A. Calleja
JDJosé Luís Díez-Martín
José Luís Díez-Martín
AHA. Hidalgo-Vega
A. Hidalgo-Vega
CAR-T cell therapy represents a therapeutic revolution in the prognosis and treatment of patients with certain types of hematological cancer. However, they also pose new challenges in the healthcare, regulatory and financial fields. The aim of the RET-A project was to undertake a strategic reflection on the management of CAR-T therapies within the Spanish National Health System, to agree on recommendations that will help to better deal with the new context introduced by these cell therapies in the present and in the future. This think tank involved 40 key agents and opinion leaders. The experts identified three great challenges for implementing advanced therapies in Spain: therapeutic individualisation, with a multidisciplinary approach; acceleration of access times, by minimizing bureaucracy; and increase in the number of centers qualified to manage the CAR-T therapies in the NHS. The experts agreed on the ideal criteria for designating those qualified centers. They also agreed on a comprehensive CAR-T care pathway with the timings and roles which would ideally be involved in each part of the process.

1 January 2020 in Journal of Venomous Animals and Toxins including Tropical Diseases
Verified
Journal Article
Open access
PDF file
RSRoberta Tancredi Francesco dos Santos
Roberta Tancredi Francesco dos Santos
MSMarcelo Florencio Passos Silva
Marcelo Florencio Passos Silva
RPRafael Marques Porto
Rafael Marques Porto
ILIvo Lebrun
Ivo Lebrun
LGLuís Roberto de Camargo Gonçalves
Luís Roberto de Camargo Gonçalves
FAFernando Abdalla
Fernando Abdalla
Here, we described the presence of a neurotoxin with phospholipase A2 activity isolated from Micrurus lemniscatus venom (Mlx-8) with affinity for muscarinic acetylcholine receptors (mAChRs). The purification, molecular mass determination, partial amino acid sequencing, phospholipase A2 activity determination, inhibition of the binding of the selective muscarinic ligand [3H]QNB and inhibition of the total [3H]inositol phosphate accumulation in rat hippocampus of the Mlx-8 were determined. Thirty-one fractions were collected from HPLC chromatography, and the Mlx-8 toxin was used in this work. The molecular mass of Mlx-8 is 13.628 Da. Edman degradation yielded the following sequence: NLYQFKNMIQCTNTRSWL-DFADYG-CYCGRGGSGT. The Mlx-8 had phospholipase A2 enzymatic activity. The pKi values were determined for Mlx-8 toxin and the M1 selective muscarinic antagonist pirenzepine in hippocampus membranes via [3H]QNB competition binding assays. The pKi values obtained from the analysis of Mlx-8 and pirenzepine displacement curves were 7.32 ± 0.15, n = 4 and 5.84 ± 0.18, n = 4, respectively. These results indicate that Mlx-8 has affinity for mAChRs. There was no effect on the inhibition ability of the [3H]QNB binding in hippocampus membranes when 1 µM Mlx-8 was incubated with 200 µM DEDA, an inhibitor of phospholipase A2. This suggests that the inhibition of the phospholipase A2 activity of the venom did not alter its ability to bind to displace [3H]QNB binding. In addition, the Mlx-8 toxin caused a blockade of 43.31 ± 8.86%, n = 3 and 97.42 ± 2.02%, n = 3 for 0.1 and 1 µM Mlx-8, respectively, on the total [3H]inositol phosphate content induced by 10 µM carbachol. This suggests that Mlx-8 inhibits the intracellular signaling pathway linked to activation of mAChRs in hippocampus. The results of the present work show, for the first time, that muscarinic receptors are also affected by the Mlx-8 toxin, a muscarinic ligand with phospholipase A2 characteristics, obtained from the venom of the Elapidae snake Micrurus lemniscatus, since this toxin was able to compete with muscarinic ligand [3H]QNB in hippocampus of rats. In addition, Mlx-8 also blocked the accumulation of total [3H]inositol phosphate induced by muscarinic agonist carbachol. Thus, Mlx-8 may be a new pharmacological tool for examining muscarinic cholinergic function.